跳至主要内容
临床试验/NCT02846350
NCT02846350已完成不适用

Positive Connections: COPA2

University of Miami2 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2016年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
360
试验地点
2
主要终点
HIV viral Load (VL)

研究概览

简要总结

This study proposes to assess the impact of a provider-based intervention to enhance re-engagement and improve retention, adherence, persistence and viral load among challenging patients in Argentina

详细描述

Motivational Interviewing (MI) has primarily been utilized as a counseling strategy by therapists to counter addiction and improve lifestyle behaviors.

This application proposes to train physicians to utilize MI to promote re-engagement in HIV care and to sustain retention and adherence. The study will increase the reach of the original pilot study and increase its generalizability, expanding the patient population to a wide variety of public and private clinic and hospital patients, including transgender women, drug users, men who have sex with men (MSM), and heterosexual men and women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV seropositive
  • At least 18 years of age (there will be no upper age range)
  • "Challenging" HIV-infected patients, defined as 1) diagnosed for > 6 months and having detectable viral load > 500 copies/mL at last assessment following 6 months of ART prescription, AND 2) not retained in care, i.e., 3 missed pharmacy pick-ups in the last 6 consecutive months, or not attending a physician visit in the last 12 months or more

排除标准

  • Participants with delirium and/or psychosis will be excluded.
  • There are no exclusions based on literacy as all materials will be administered using an audio computer assisted self-interview system (ACASI) supervised by assessors.

结局指标

主要结局

HIV viral Load (VL)

时间窗: Less than 6 months detectable VL

VL will be assessed by blood sampling. Viral suppression (HIV VL \<200 copies/mL) will be the primary dichotomous outcome; a secondary dichotomization will be made among detectable patients with VL \<1000 and those with VL \>1000.

Retention in care

时间窗: 2 years

Defined as the number of missed clinic appointments (i.e., "no shows" not cancelled in advance by patients or clinic staff) in the 6 months preceding assessment.

Medication persistence

时间窗: 2 years

Medication persistence is the time to treatment discontinuation, with a permissible gap of \< 30 days, participants will be considered to have discontinued the regimen if a therapy gap = \> 30 days occurs.

Medication adherence: Self-report

时间窗: 2 years

Proportion of self-reported adherent participants over time

Medication adherence: Hair sample

时间窗: 2 years

Adherence by hair sample to estimate an average concentration of ARV medication exposure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

DEBORAH JONES

Professor of Psychiatry & Behavioral Sciences

University of Miami

研究点 (2)

Loading locations...

相似试验